Zacks Investment Research on MSN
LLY's GLP-1 Duo Boosts Sales Amid Rising Demand for Obesity Drugs
Eli Lilly’s LLY key top-line drivers are its GLP-1 medicines, Mounjaro for type II diabetes and Zepbound for obesity. Despite ...
There are countless tools out there that can generate images, including ChatGPT and Midjourney. These are basically ...
4don MSN
2 Monster Stocks in the Making
In fact, these stocks often have even more upside than better-established ones. The weight loss market could reach $150 ...
Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results